NASDAQ:ADXS

Advaxis - ADXS Stock Forecast, Price & News

$2.10

-0.01 (-0.47%)

(As of 02/3/2023 12:00 AM ET)

Add

Compare

Today's Range: $2.01
▼
$2.16
50-Day Range: N/A
52-Week Range: $1.00
▼
$11.52

Volume: 6,336 shs
Average Volume: 10,529 shs
Market Capitalization: $3.81 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Advaxis

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.

Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advaxis and its competitors with MarketBeat's FREE daily newsletter.

ADXS Stock News Headlines

January 31, 2023 | americanbankingnews.com

Advaxis (NASDAQ:ADXS) Coverage Initiated at StockNews.com

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advaxis and its competitors with MarketBeat's FREE daily newsletter.

ADXS Company Calendar

Today: 2/04/2023
Fiscal Year End: 10/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ADXS
CUSIP: N/A
CIK: 1100397
Web: www.advaxis.com
Phone: (609) 452-9813
Fax: 609-452-9818
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($8.93)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-17,860,000.00
Net Margins: N/A
Pretax Margin: -6,064.80%
Return on Equity: -54.02%
Return on Assets: -47.27%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 15.64
Quick Ratio: 15.64

Sales & Book Value

Annual Sales: $3.24 million
Price / Sales: 1.18
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $21.36 per share
Price / Book: 0.10

Miscellaneous

Outstanding Shares: 1,816,000
Free Float: 1,810,000
Market Cap: $3.81 million
Optionable: Not Optionable
Beta: 2.44

Key Executives

Ken Berlin
President, Chief Executive Officer & Director

Igor Gitelman
VP-Finance, Chief Financial & Accounting Officer

Andres A. Gutiérrez
Chief Medical Officer & Executive Vice President

Michael Grace
Vice President-Technical Operations

Key Competitors

AstraZeneca
NYSE:AZN

View All Competitors

ADXS Stock - Frequently Asked Questions

How have ADXS shares performed in 2023?: Advaxis' stock was trading at $1.90 at the beginning of 2023. Since then, ADXS shares have increased by 10.5% and is now trading at $2.10.
View the best growth stocks for 2023 here.
What other stocks do shareholders of Advaxis own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Advaxis investors own include Inovio Pharmaceuticals (INO), Madrigal Pharmaceuticals (MDGL), Merck & Co., Inc. (MRK), Anavex Life Sciences (AVXL), VistaGen Therapeutics (VTGN), Novavax (NVAX), Highpower International (HPJ), OPKO Health (OPK) and Athersys (ATHX).

What is Advaxis' stock symbol?: Advaxis trades on the NASDAQ under the ticker symbol "ADXS."
How do I buy shares of Advaxis?: Shares of ADXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Advaxis' stock price today?: One share of ADXS stock can currently be purchased for approximately $2.10.
How much money does Advaxis make?: Advaxis (NASDAQ:ADXS) has a market capitalization of $3.81 million and generates $3.24 million in revenue each year. The company earns $-17,860,000.00 in net income (profit) each year or ($8.93) on an earnings per share basis.
How can I contact Advaxis?: Advaxis' mailing address is 9 DEER PARK DRIVE SUITE K-1, MONMOUTH JUNCTION NJ, 08852. The official website for the company is www.advaxis.com. The company can be reached via phone at (609) 452-9813, via email at tim@lifesciadvisors.com, or via fax at 609-452-9818.

This page (NASDAQ:ADXS) was last updated on 2/5/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial